441 related articles for article (PubMed ID: 33305554)
1. Gender differences in treatment of Coronavirus Disease-2019.
Ambrosino I; Barbagelata E; Corbi G; Ciarambino T; Politi C; Moretti AM
Monaldi Arch Chest Dis; 2020 Dec; 90(4):. PubMed ID: 33305554
[TBL] [Abstract][Full Text] [Related]
2. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
Bokharee N; Khan YH; Khokhar A; Mallhi TH; Alotaibi NH; Rasheed M
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1219-1244. PubMed ID: 33719819
[No Abstract] [Full Text] [Related]
4. COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review.
Raj CTD; Kandaswamy DK; Danduga RCSR; Rajasabapathy R; James RA
Arch Microbiol; 2021 Jul; 203(5):2043-2057. PubMed ID: 33555378
[TBL] [Abstract][Full Text] [Related]
5. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
6. Treatment of SARS-CoV-2: How far have we reached?
Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
[TBL] [Abstract][Full Text] [Related]
7. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
Wang D; Li Z; Liu Y
J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
[TBL] [Abstract][Full Text] [Related]
9. A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.
Kheirabadi D; Haddad F; Mousavi-Roknabadi RS; Rezaeisadrabadi M; Dehghan H; Fazlzadeh A
J Med Virol; 2021 May; 93(5):2705-2721. PubMed ID: 33463727
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for COVID-19: The reality and challenges.
Jean SS; Lee PI; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):436-443. PubMed ID: 32307245
[TBL] [Abstract][Full Text] [Related]
11. Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
Miller-Handley H; Luckett K; Govil A
Adv Chronic Kidney Dis; 2020 Sep; 27(5):434-441. PubMed ID: 33308510
[TBL] [Abstract][Full Text] [Related]
12. Emerging treatment strategies for COVID-19 infection.
Gavriatopoulou M; Ntanasis-Stathopoulos I; Korompoki E; Fotiou D; Migkou M; Tzanninis IG; Psaltopoulou T; Kastritis E; Terpos E; Dimopoulos MA
Clin Exp Med; 2021 May; 21(2):167-179. PubMed ID: 33128197
[TBL] [Abstract][Full Text] [Related]
13. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
[TBL] [Abstract][Full Text] [Related]
14. Possible treatment and strategies for COVID-19: review and assessment.
Trivedi N; Verma A; Kumar D
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
[TBL] [Abstract][Full Text] [Related]
15. Some drugs for COVID-19.
Med Lett Drugs Ther; 2020 Apr; 62(1595):49-50. PubMed ID: 32324177
[No Abstract] [Full Text] [Related]
16. Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review.
Jomah S; Asdaq SMB; Al-Yamani MJ
J Infect Public Health; 2020 Sep; 13(9):1187-1195. PubMed ID: 32773212
[TBL] [Abstract][Full Text] [Related]
17. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
Costanzo M; De Giglio MAR; Roviello GN
Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
[TBL] [Abstract][Full Text] [Related]
19. Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Yadav AK; Wen S; Xu X; Yu L
Ann Palliat Med; 2021 Jan; 10(1):707-720. PubMed ID: 33440983
[TBL] [Abstract][Full Text] [Related]
20. One year update on the COVID-19 pandemic: Where are we now?
Mishra SK; Tripathi T
Acta Trop; 2021 Feb; 214():105778. PubMed ID: 33253656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]